Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
Public ClinicalTrials.gov record NCT03525262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized Controlled Trial of Stereotactic Ablative Body Radiotherapy (SAbR) With or Without Neurovascular Sparing for Erectile Function Preservation in Localized Prostate Cancer
Study identification
- NCT ID
- NCT03525262
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- 30Gy (Gray) planning target volume (PTV) Radiation
Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2018
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2029
- Last update posted
- Jun 3, 2025
2018 – 2029
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF ( Department of Radiation Oncology University of California San Francisco) | San Francisco | California | 94143 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| Penrose Hospital | Colorado Springs | Colorado | 80907 | — |
| University of Michigan- Michigan Medicine | Ann Arbor | Michigan | 48109 | — |
| Stony Brook University Cancer Center | Stony Brook | New York | 11794 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Penn Medicine Radiation Oncology | Philadelphia | Pennsylvania | 19104 | — |
| UT Southwestern Cancer Center | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03525262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03525262 live on ClinicalTrials.gov.